CIN-QUIN Drug Patent Profile
✉ Email this page to a colleague
When do Cin-quin patents expire, and what generic alternatives are available?
Cin-quin is a drug marketed by Solvay and is included in five NDAs.
The generic ingredient in CIN-QUIN is quinidine sulfate. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cin-quin
A generic version of CIN-QUIN was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
Summary for CIN-QUIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 3,946 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CIN-QUIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CIN-QUIN
US Patents and Regulatory Information for CIN-QUIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | CIN-QUIN | quinidine sulfate | CAPSULE;ORAL | 085296-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Solvay | CIN-QUIN | quinidine sulfate | TABLET;ORAL | 084932-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Solvay | CIN-QUIN | quinidine sulfate | CAPSULE;ORAL | 085297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
